Brainstorm Cell Therapeutics Inc
(OTCPK:BCLI)
$
1.1628
-0.037 (-3.1%)
Market Cap: 12.83 Mil
Enterprise Value: 14.18 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 29/100 Brainstorm Cell Therapeutics Inc (BCLI) Transcripts
- 1